Article
Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.
Leukemia - 1 Aug 2009
Jeha S, Pei D, Raimondi S C, Onciu M, Campana D, Cheng C, Sandlund J T, Ribeiro R C, Rubnitz J E, Howard S C, Downing J R, Evans W E, Relling M V, Pui C-H
Abstract excerpt
To evaluate the impact of contemporary therapy on the clinical outcome of children with pre-B acute lymphoblastic leukemia (ALL) and the t(1;19)/TCF3/PBX1, we analyzed 735 patients with B-cell precursor ALL treated in four successive protocols at St Jude Children's Research Hospital. The 41 patients with the t(1;19) had a comparable event-free survival to that of the 694 patients with other B-cell precursor ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
